KINTOR PHARMA-B (09939) received CEO Tong You's acquisition of an additional 1.45 million shares.

KINTOR PHARMA-B (09939) announced that Dr. Tong Youzhi, Chairman of the Board of Directors, Executive Director, and Chief Executive Officer of the company, purchased an additional 200,000 shares of the company in the open market through his wholly-owned company KT International Investment Limited on March 28, 2025, using his own funds of 259,000 Hong Kong dollars (with an average transaction price of 1.295 Hong Kong dollars per share). This represents approximately 0.0447% of the total issued share capital of the company as of the date of this announcement. In addition, Dr. Tong exercised the rights granted in connection with 1.25 million restricted stock units (equivalent to 1.25 million ordinary shares of the company) awarded under the company's 2020 employee incentive plan. These shares were fully vested on March 31, 2025. Following this purchase, Dr. Tong now holds a total of 49,200,030 shares in the company, representing approximately 10.99% of the total issued share capital of the company as of the date of this announcement. Based on publicly available information and to the best knowledge of the board of directors, the company still maintains an adequate public float of issued shares. The announcement stated that this additional purchase demonstrates Dr. Tong's strong confidence in the company's commercial prospects and growth potential, as well as his full recognition of the long-term investment value of the company. The group will continue to focus on the dermatology field, deepen its existing skincare product offerings, expand product coverage areas, accelerate the development of new skincare products, and further enrich its product portfolio. At the same time, considering the market potential of functional ingredients, the company is actively exploring the skincare ingredient markets of KT-939 and KX-826, seeking cooperation opportunities with skincare brands, and continuously expanding its skincare ingredient business to cultivate new profit growth points.